Thomson Hospital Kota Damansara appoints CEO
Analysis based on 6 articles · First reported Jul 02, 2026 · Last updated Jul 02, 2026
The appointment of Dr Savitha Dharan as CEO of Thomson Hospital Kota Damansara is expected to positively impact the hospital's operational efficiency and strategic growth, potentially leading to increased revenue and market share for its parent company, List of life sciences. This leadership change could signal a period of innovation and enhanced patient care, which may be viewed favorably by investors in the healthcare sector.
Thomson Hospital Kota Damansara announced the appointment of Dr Savitha Dharan as its new Chief Executive Officer, effective July 1, 2026. Dr Savitha brings over 20 years of experience in clinical practice and healthcare leadership, including senior roles in private healthcare groups. Dato' Dr. Adzuan Rahman, Group CEO of List of life sciences, expressed confidence that Dr Savitha Dharan's leadership will strengthen Thomson Hospital Kota Damansara's position as a leading multidisciplinary tertiary healthcare provider and advance its commitment to clinical excellence, innovation, and value-driven care. Dr Savitha Dharan's appointment underscores Thomson Hospital Kota Damansara's commitment to clinician-led leadership and patient-centered decision-making.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard